A thought.
ACL has just put out a bad ann on its Phase III trial. Not just bad but really unequivocally bad. Expect the ACL price to get blown to smithereens.
On top of other recent trial failures this may put a lid on enthusiasm for ramping up NEU's price ahead of the Phase II results. Also, I would expect the NEU price to take a dip today. It did the last time there was a dud trial result for an unrelated company.
The Bot, page-33
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.40 |
Change
1.130(8.52%) |
Mkt cap ! $1.840B | |||
| Open | High | Low | Value | Volume |
| $13.80 | $14.45 | $13.53 | $15.04M | 1.062M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 871 | $14.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.42 | 3650 | 3 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |